Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Byars

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Infection and Immunity|May 1, 1984
Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigsN E Byars
Research in Immunology|June 1, 1992
Syntex adjuvant formulationA C Allison, N E Byars
Seminars in Immunology|September 1, 1990
Adjuvant formulations and their mode of actionA C Allison, N E Byars
Molecular Immunology|March 1, 1991
Immunological adjuvants: desirable properties and side-effectsA C Allison, N E Byars
Advances in Experimental Medicine and Biology|January 1, 1992
Immunological adjuvantsA C Allison, N E Byars
Journal of Immunological Methods|December 24, 1986
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunityA C Allison, N E Byars
Agents and Actions|June 1, 1980
Inhibition of rat intestinal anaphylaxis by various anti-inflammatory agentsN E Byars, R W Ferraresi
Vaccine|September 1, 1987
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunityN E Byars, A C Allison
Pharmaceutical Biotechnology|January 1, 1995
Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccinesD M Lidgate, N E Byars
Biotechnology (Reading, Mass.)|January 1, 1992
Immunological adjuvants and their mode of actionA C Allison, N E Byars
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Infection and Immunity|May 1, 1984
Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigsN E Byars
Research in Immunology|June 1, 1992
Syntex adjuvant formulationA C Allison, N E Byars
Seminars in Immunology|September 1, 1990
Adjuvant formulations and their mode of actionA C Allison, N E Byars
Molecular Immunology|March 1, 1991
Immunological adjuvants: desirable properties and side-effectsA C Allison, N E Byars
Advances in Experimental Medicine and Biology|January 1, 1992
Immunological adjuvantsA C Allison, N E Byars
Journal of Immunological Methods|December 24, 1986
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunityA C Allison, N E Byars
Agents and Actions|June 1, 1980
Inhibition of rat intestinal anaphylaxis by various anti-inflammatory agentsN E Byars, R W Ferraresi
Vaccine|September 1, 1987
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunityN E Byars, A C Allison
Pharmaceutical Biotechnology|January 1, 1995
Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccinesD M Lidgate, N E Byars
Biotechnology (Reading, Mass.)|January 1, 1992
Immunological adjuvants and their mode of actionA C Allison, N E Byars
Pageof 2